PepGen Inc. (PEPG)
4.36
-0.68
(-13.49%)
USD |
NASDAQ |
Nov 13, 16:00
4.40
+0.04
(+0.92%)
After-Hours: 19:59
PepGen Price : 4.36 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 5.08 | 5.08 | 4.34 | 4.36 | 5.920M |
| Nov 12, 2026 | 5.26 | 5.35 | 4.84 | 5.04 | 12.09M |
| Nov 11, 2026 | 5.40 | 5.90 | 5.105 | 5.26 | 16.01M |
| Nov 10, 2026 | 5.545 | 6.45 | 4.42 | 4.61 | 106.52M |
| Nov 09, 2026 | 2.52 | 2.52 | 2.280 | 2.39 | 1.376M |
| Nov 06, 2026 | 2.33 | 2.52 | 2.33 | 2.47 | 998249.0 |
| Nov 05, 2026 | 2.55 | 2.55 | 2.22 | 2.32 | 958766.0 |
| Nov 04, 2026 | 2.53 | 2.69 | 2.375 | 2.45 | 1.801M |
| Nov 03, 2026 | 2.36 | 2.485 | 2.36 | 2.46 | 613447.0 |
| Nov 02, 2026 | 2.39 | 2.467 | 2.305 | 2.35 | 565915.0 |
| Oct 30, 2026 | 2.40 | 2.405 | 2.22 | 2.36 | 1.129M |
| Oct 29, 2026 | 2.54 | 2.62 | 2.40 | 2.41 | 770037.0 |
| Oct 28, 2026 | 2.58 | 2.64 | 2.485 | 2.53 | 767843.0 |
| Oct 27, 2026 | 2.49 | 2.62 | 2.47 | 2.60 | 1.332M |
| Oct 26, 2026 | 2.51 | 2.675 | 2.460 | 2.49 | 906889.0 |
| Oct 23, 2026 | 2.68 | 2.80 | 2.44 | 2.52 | 1.162M |
| Oct 22, 2026 | 2.71 | 2.83 | 2.65 | 2.70 | 1.042M |
| Oct 21, 2026 | 2.89 | 2.990 | 2.72 | 2.72 | 1.174M |
| Oct 20, 2026 | 2.66 | 2.94 | 2.62 | 2.87 | 2.769M |
| Oct 19, 2026 | 2.55 | 2.73 | 2.495 | 2.70 | 1.083M |
| Oct 16, 2026 | 2.56 | 2.69 | 2.50 | 2.60 | 1.203M |
| Oct 15, 2026 | 2.30 | 2.60 | 2.30 | 2.53 | 764202.0 |
| Oct 14, 2026 | 2.44 | 2.49 | 2.26 | 2.32 | 917348.0 |
| Oct 13, 2026 | 2.48 | 2.60 | 2.41 | 2.50 | 1.218M |
| Oct 12, 2026 | 2.61 | 2.61 | 2.48 | 2.49 | 315769.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Korsana Biosciences, Inc. | 31.65 |
| IRulya Therapeutics, Inc. | 39.80 |
| Q32 Bio, Inc. | 8.71 |
| Bridgebio Oncology Therapeutics, Inc. | 2.14 |
| Oncolytics Biotech, Inc. | 0.37 |
Price Related Metrics
| Price to Book Value | 2.93 |
| Earnings Yield | -24.34% |
| Market Cap | 301.98M |